ModeX Therapeutics has started dosing patients with its tetraspecific T-cell engager, MDX2003, for relapsed or refractory B-cell lymphoma.The post ModeX...
MSD and Google Cloud have formed a multi-year partnership, investing up to $1bn, to advance agentic AI enterprise transformation.The post...
Artera has secured CE marking under the EU IVDR for its ArteraAI Prostate Biopsy and Breast Cancer assays, expanding the...
Roche has reported new findings from the Phase III METEOROID trial of Enspryng in adults and adolescents with MOGAD.The post...
Biocon has received a Notice of Compliance from Health Canada for Bosaya and Vevzuo, both biosimilars referencing Prolia and Xgeva,...
Medtronic has completed the acquisition of CathWorks, a company specialising in advancing the diagnosis and treatment of CAD, for $585m.The...
Atsena Therapeutics is set to proceed with the Part C cohort of its Phase I/II/III LIGHTHOUSE trial of ATSN-201 in...
Asahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company.The post Asahi Kasei acquires German company...
The Bruker Microbiology & Infection Diagnostics division has announced the European launch of its MyGenius PRO automated S2A molecular diagnostics...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.